Comparative Efficacy and Safety of Liraglutide Versus Metformin in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Indrajit Banerjee, Mooroogiah Krissheeven, Nishant Pandey, Shradha Banerjee, Jared Robinson, Indraneel Banerjee · 2026
Read Comparative Efficacy and Safety of Liraglutide Versus Metformin in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Indrajit Banerjee, Mooroogiah Krissheeven, Nishant Pandey, Shradha Banerjee, Jared Robinson, Indraneel Banerjee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634180.txt.
Description
Indrajit Banerjee and five co-authors published a systematic review and meta-analysis in twenty twenty-six comparing liraglutide with metformin for women with polyendocrine metabolic ovarian syndrome. The condition, long called polycystic ovary syndrome, affects about one in eight women and reaches far beyond fertility. Metformin is the standard drug; liraglutide, a GLP-1 agonist, is a newer challenger.
The review followed PRISMA twenty twenty guidelines with a protocol registered on PROSPERO. It set out to compare the two drugs across the outcomes that matter clinically, from weight and blood sugar to hormones and safety. The authors aim to give clinicians a current, head-to-head evidence base for tailoring treatment to each woman.
Catalog record
| CREATOR | Indrajit Banerjee, Mooroogiah Krissheeven, Nishant Pandey, Shradha Banerjee, Jared Robinson, Indraneel Banerjee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |